Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Clinical trial NCT07194980 · RECRUITING
Trial details
- NCT number
- NCT07194980
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2029-10-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.